Back
Catalyst Pharmaceuticals, Inc. Vs. Gitlab, Inc. Industry Stock Comparison
Buy
81
CPRX
Catalyst Pharmaceuticals, Inc.
Last Price:
$24.43
Seasonality Move:
6.75%
Sell
23
GTLB
Gitlab, Inc.
Last Price:
$37.50
Seasonality Move:
-19.14%
Buy
81
Catalyst Pharmaceuticals, Inc. (CPRX)
is a Buy
Is Catalyst Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Catalyst Pharmaceuticals, Inc. [CPRX] share price is $24.23. The Score for CPRX is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
-
CPRX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
23
Gitlab, Inc. (GTLB)
is a Sell
Is Gitlab, Inc. a Buy, Sell or Hold?
-
The current Gitlab, Inc. [GTLB] share price is $37.57. The Score for GTLB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
GTLB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals, Inc.'s stock price today?
-
The Catalyst Pharmaceuticals, Inc. share price today is $24.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight selling pressure.
GTLB Stock Price Chart
What is Gitlab, Inc.'s stock price today?
-
The Gitlab, Inc. share price today is $37.57Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTLB is experiencing slight selling pressure.
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.48 | Buy |
| Relative Strength Index (14 RSI): | 62.65 | Buy |
| Chaikin Money Flow: | -283222 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.78 - 23.9) | Buy |
| Bollinger Bands (100): | (19.93 - 22.75) | Buy |
GTLB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.51 | Sell |
| Relative Strength Index (14 RSI): | 37.04 | Sell |
| Chaikin Money Flow: | -709053 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.91 - 41.97) | Sell |
| Bollinger Bands (100): | (40.96 - 48.4) | Sell |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.99 | Buy |
| 20-day SMA: | 23.44 | Buy |
| 50-day SMA: | 22.4 | Buy |
| 200-day SMA: | 22.17 | Buy |
| 8-day EMA: | 23.9 | Buy |
| 20-day EMA: | 23.47 | Buy |
| 50-day EMA: | 22.29 | Buy |
| 200-day EMA: | 14.02 | Buy |
GTLB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.26 | Sell |
| 20-day SMA: | 39.27 | Sell |
| 50-day SMA: | 43.35 | Sell |
| 200-day SMA: | 45.54 | Sell |
| 8-day EMA: | 38.31 | Sell |
| 20-day EMA: | 39.56 | Sell |
| 50-day EMA: | 42.08 | Sell |
| 200-day EMA: | 46.53 | Sell |
Catalyst Pharmaceuticals, Inc. Earnings Growth & CPRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.08 per share.
Gitlab, Inc. Earnings Growth & GTLB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.26 per share.
Catalyst Pharmaceuticals, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gitlab, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||